IFI-M · PCA Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-01127 // MULTI-AXIS · IFI-M

PCA Tri-Axis Dominant-Primary Series I-BL

Brassica nigra

Black Mustard

Tier IPCA Tri-Axis Dominant-Primary Series

Target Trait

1.1×

fold-change

Sharp-dominant tri-axis C+A modulated fold-change

Technical Specifications

SKU

SS-F-M3-01127

Genomic Edits

6

GC Content

46%

Construct Length

4,230 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPA1 + TRPM8 + Polyphenol-astringency axis

IFI Score

110

Pathway Edits

  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent PCA pathway operation
  • Cross-pathway regulatory circuit for sharp-dominant PCA triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and Polyphenol-astringency axis pathways simultaneously engineeredSharp-dominant tri-axis expression strategy (PCA) with cross-pathway flux managementBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I PCA triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and astringency axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?